HuR shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

HuR shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
HuR shRNA Plasmid (h)

Product Specs
ItemHuR shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-35619-SH
Quantity20 µg
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene NameELAV like RNA binding protein 1
NCBI Gene AliasesELAV1, HUR, Hua, MelG
RNA TypeshRNA Clones

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBCLife sciencesMay 1, 2023Marni R, Malla M, Chakraborty A, Malla R.

(2) LncRNA RMRP aggravates LPS-induced HK-2 cell injury and AKI mice kidney injury by upregulating COX2 protein via targeting ELAVL1International immunopharmacologyMarch 1, 2023Xia H, Shanshan X, Sumeng L, Fang X, Tao Z, Cheng C.

(3) Down-regulation of HuR inhibits pathological angiogenesis in oxygen-induced retinopathyExperimental eye researchFebruary 1, 2023Huang XM, Liu Q, Xu ZY, Yang XH, Xiao F, Ouyang PW, Yi WZ, Zhao N, Meng J, Cui YH, et al.

(4) Docetaxel-triggered SIDT2/NOX4/JNK/HuR signaling axis is associated with TNF-α-mediated apoptosis of cancer cellsBiochemical pharmacologyJanuary 1, 2022Wang LJ, Chiou JT, Lee YC, Chang LS.

(5) HuR drives lung fibroblast differentiation but not metabolic reprogramming in response to TGF-β and hypoxiaRespiratory researchDecember 28, 2021Trivlidis J, Aloufi N, Al-Habeeb F, Nair P, Azuelos I, Eidelman DH, Baglole CJ.

(6) HuR/Cx40 downregulation causes coronary microvascular dysfunction in type 2 diabetesJCI insightNovember 8, 2021Si R, Cabrera JTO, Tsuji-Hosokawa A, Guo R, Watanabe M, Gao L, Lee YS, Moon JS, Scott BT, Wang J, et al.

(7) CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia-reperfusion injuryJournal of cellular and molecular medicineJune 10, 2021Sui M, Xu D, Zhao W, Lu H, Chen R, Duan Y, Li Y, Zhu Y, Zhang L, Zeng L.

(8) Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cellsBiochemical pharmacologyJune 1, 2021Chiou JT, Lee YC, Huang CH, Wang LJ, Shi YJ, Chang LS.

(9) Translational regulation of Chk1 expression by eIF3a via interaction with the RNA-binding protein HuRThe Biochemical journalMay 29, 2020Dong Z, Liu J, Zhang JT.

(10) miR-519 regulates the proliferation of breast cancer cells via targeting human antigen ROncology lettersFebruary 1, 2020Ren L, Li Y, Zhao Q, Fan L, Tan B, Zang A, Yang H.

(11) Regulation of Kv11.1 potassium channel C-terminal isoform expression by the RNA-binding proteins HuR and HuDThe Journal of biological chemistryDecember 21, 2018Gong Q, Stump MR, Zhou Z.

(12) MiR-19b non-canonical binding is directed by HuR and confers chemosensitivity through regulation of P-glycoprotein in breast cancerBiochimica et biophysica acta. Gene regulatory mechanismsNovember 1, 2018Thorne JL, Battaglia S, Baxter DE, Hayes JL, Hutchinson SA, Jana S, Millican-Slater RA, Smith L, Teske MC, Wastall LM, et al.

(13) RNA binding protein HuR promotes osteosarcoma cell progression via suppressing the miR-142-3p/HMGA1 axisOncology lettersAugust 1, 2018Pan W, Pang J, Ji B, Wang Z, Liu C, Cheng Y, Zhang L.

(14) The induced RNA-binding protein, HuR, targets 3'-UTR region of IL-6 mRNA and enhances its stabilization in periodontitisClinical and experimental immunologyJune 1, 2018Ouhara K, Munenaga S, Kajiya M, Takeda K, Matsuda S, Sato Y, Hamamoto Y, Iwata T, Yamasaki S, Akutagawa K, et al.

(15) Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agentsBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieJune 1, 2018Xu W, Chen C, Xu R, Li Y, Hu R, Li Z, Zhu X.

(16) Inhibition of IRES-dependent translation of caspase-2 by HuR confers chemotherapeutic drug resistance in colon carcinoma cellsOncotargetApril 6, 2018Badawi A, Biyanee A, Nasrullah U, Winslow S, Schmid T, Pfeilschifter J, Eberhardt W.

(17) HuR facilitates cancer stemness of lung cancer cells via regulating miR-873/CDK3 and miR-125a-3p/CDK3 axisBiotechnology lettersApril 1, 2018Zhang Y, Yang L, Ling C, Heng W.

(18) Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cellsAutophagyJanuary 1, 2018Zhang Z, Yao Z, Wang L, Ding H, Shao J, Chen A, Zhang F, Zheng S.

(19) Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasisScientific reportsAugust 29, 2017Lee SK, Park KK, Kim HJ, Park J, Son SH, Kim KR, Chung WY.

(20) Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2Cancer lettersMay 1, 2017Badawi A, Hehlgans S, Pfeilschifter J, Rödel F, Eberhardt W.

Be the First to Write a Review!